| Literature DB >> 11429544 |
J B Rottman1, T Smith, J R Tonra, K Ganley, T Bloom, R Silva, B Pierce, J C Gutierrez-Ramos, E Ozkaynak, A J Coyle.
Abstract
The inducible costimulatory molecule (ICOS) is expressed on activated T cells and participates in a variety of important immunoregulatory functions. After the induction of experimental allergic encephalomyelitis in SJL mice with proteolipid protein (PLP), brain ICOS mRNA and protein were up-regulated on infiltrating CD3+ T cells before disease onset. ICOS blockade during the efferent immune response (9-20 days after immunization) abrogated disease, but blockade during antigen priming (1-10 days after immunization) exacerbated disease. Upon culture with PLP and compared with immunized controls, splenocytes produced either decreased interferon-gamma (IFN-gamma, in efferent blockade) or excessive IFN-gamma (in priming blockade). PLP-specific immunoglobulin G1 was decreased in animals treated with anti-ICOS during antigen priming, but not in other groups.Entities:
Mesh：
Substances：
Year: 2001 PMID： 11429544 DOI： 10.1038/89750
Source DB: PubMed Journal: Nat Immunol ISSN： 1529-2908 Impact factor: 25.606